期刊文献+

外周血Lunx mRNA、Muc1 mRNA、CEA联合检测对非小细胞肺癌微转移的诊断价值 被引量:3

Diagnosis of micrometastases by detection of Lunx mRNA,Muc1 mRNA and CEA in peripheral blood of patients with non-small cell lung cancer
下载PDF
导出
摘要 目的检测非小细胞肺癌(non-small cell lung cancer,NSCLC)患者外周血中肺特异性X蛋白(LunxmRNA)、黏蛋白基因1(Muc1 mRNA)及CEA,探讨其对NSCLC微转移的诊断价值及临床意义。方法 72例NSCLC癌患者、10例肺良性疾病患者及12例健康志愿者,以逆转录-聚合酶链反应(reserve transcriptase-polymerasechain reaction,RT-PCR)方法,对其外周血进行Lunx mRNA和Muc1 mRNA的检测;以免疫化学发光测定法,检测其血清的CEA水平。结果 Lunx mRNA和Muc1 mRNA在NSCLC患者外周血中的表达率与肺良性病变组和正常对照组比较差异有统计学意义(P<0.01);其表达与NSCLC组织分化程度和临床分期相关(P<0.05),Muc1 mRNA的表达还与组织学类型有关(P<0.05)。以多种指标多种方法联合检测阳性率为最高。结论 Lunx mRNA和Muc1 mRNA是检测NSCLC微转移的良好指标。两者联合CEA检测可以提高肺癌检出率。 Objective To detect the expression of Lunx mRNA,Muc1 mRNA and CEA in peripheral blood of patients with non-small cell lung cancer,and to explore the clinical and diagnostic value to the micro-metastasis of NSCLC. Methods RT-PCR was used to detect the Lunx mRNA and Muc1 mRNA in peripheral blood from 72 patients with NSCLC,10 patients with benign lung diseases and 12 healthy volunteers were served as controls.Serum of CEA was measured by electrochemiluminescence. Results Positive rate of Lunx mRNA and Muc1 mRNA in peripheral blood of patients with NSCLC was significant different compared with the other two groups(P0.01),the expression of Lunx mRNA was related with histological grade and clinical stage of NSCLC(P0.05),while Muc1 mRNA was not only related with these,but also with the histological type(P0.05).Combined with a variety of methods,the rate of positive detection can be highest. Conclusion Lunx mRNA and Muc1 mRNA are smart detections for micrometastasis of NSCLC,and combined with CEA could improve the positive rate of NSCLC.
作者 马靓 茅国新
出处 《实用肿瘤杂志》 CAS 北大核心 2011年第5期481-485,共5页 Journal of Practical Oncology
关键词 肺肿瘤 肿瘤转移 肺特异性X蛋白 黏蛋白基因1 癌胚抗原 逆转录聚合酶链反应 lung neoplasms neoplasm metastasis Lunx mRNA Muc1 mRNA carinoembryonic antigen reverse transcriptase polymerase chain reaction
  • 相关文献

参考文献10

  • 1Wu J, Ohta Y, Minato H, et al. Nodal occult metastasis in patientswith peripheral lung adenocarcinoma of 2. 0 cm or less in diameter [J]. Ann Thorac Surg,2001,71 (6) : 1772 - 1778.
  • 2Cheng M, Chen Y,Yu X, et al. Diagnostic utility of Lunx mRNA in peripheral blood and pleural fluid in patients with primary non-small cell hmg cancer [ J ]. BMC Cancer ,2008,8 : 156.
  • 3Li SH, Wang Z, Liu XY, et al. Gene diagnosis and prognostic significance of lymph node micrometastasis after complete resection of histologically node-negative non-smaU ceil lung cancer [J]. World J Surg,2008,32 (8) :1551 - 1556.
  • 4Nosotti M, Falleni M, Palleschi A, et al. Quantitative real- time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinocmbryonic antigen marker [ J]. Chest, 2005, 128 (3) : 1539 - 1544.
  • 5Yamashita J, Matsuo A, Kurusu Y, et al. Preoperative evidence of circulating tumor cells by means of reverse transeriptase-polymerasc chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study [ J ]. Thorac Cardiovasc Surg,2002,124 (2):299 -305.
  • 6王潍博,崔言刚,姚舒洋.肺特异性X蛋白角蛋白19及癌胚抗原基因在非小细胞肺癌淋巴结微转移中的比较[J].中华肿瘤杂志,2008,30(2):121-124. 被引量:12
  • 7Michael M, Loretta H, Gerard S, et al . Lunx is a superior molecular marker for detection of non-small lung cell cancer in peripheral blood [ J ]. J Mol Diagn, 2003,5 (4) :237 -242.
  • 8Coello MC, Luketich JD, Litle VR, et al. Prognostic significance of micrometastasis in non-small cell lung cancer [ J ]. Clin Lung Cancer,2004,5 (4) :214 - 225.
  • 9Sheu CC, Yu YP, Tsai JR, et al. Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non small cell lung cancer [ J ]. Int J Cancer, 2006, 119 (6) : 1419 - 1426.
  • 10Wallace MB. Micrometastasis, molecular markers, and their future role with EUS-guided FNA [ J ]. Gastrointest Endosc,2009,69 (2) : 152 - 154.

二级参考文献14

  • 1杨浩贤,吴一龙,丁嘉安,姜格宁,周晓,陈昶,高文,陈刚.可手术非小细胞肺癌纵隔淋巴结的微转移[J].中华肿瘤杂志,2006,28(5):368-370. 被引量:11
  • 2Yanyan Li,Xueyuan Dong. BJ-TS-9,a novel humen tumour-specific gene,has potential as a biomarker of lung cancer. Neoplasis, 2005, 7 : 1073-1080.
  • 3Gerhard M, Juhl H, Kaltboff H, et al. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin oncol, 1994, 12 : 725-729.
  • 4Chomezynski P, Sacchi N. Single-step method of RNA isolation by acid guanicium thiocyanate-phenol-chloroform extraction. Anal Biolchem, 1987, 162:156-159.
  • 5Scagtiotti G, Novello S. Adjuvant chemotherapy after complete resection for early stage NSCLC. Lung Cancer, 2003 ( 42 Suppl ), 1 : S47- 51.
  • 6Doeberitz MK, Lacrnix J. Nucleic acid based techniques for the detection of rare cancer cells in clinical samples. Cancer Metastasis Rev, 1999, 18:43-64.
  • 7Kyoko Iwao, Takashi Watanabe, Yoshiyuki Fujiwara, et al. Isolation of a noval human lung specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small cell lung cancer. Int J Cancer, 2001,91:433-437.
  • 8Yamashita JI, Kurusu Y, Fujino N , et al. Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. J Thorac Cardiovasc Surg, 2000, 119:899-905.
  • 9Bostick PJ, Chatterjee S, Chi DD, et al. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastasis in the lymph nodes and blood of breast cancer patients. J Clin Oncol, 1998, 16:2632-2640.
  • 10Michael B, Mark I,William Gillanders, et al. Accurate molecular detection of non-small cell lung cancer metastases in mediastinal lymph nodes sampled by endoscopic uhrasound-guided needle aspiration. CHEST, 2005, 127:430-437.

共引文献11

同被引文献53

  • 1沈宗丽,朱月清,庄一平,吴晓柳,王亚平.流式细胞术检测肺癌患者P16蛋白表达水平的应用价值[J].中华检验医学杂志,2005,28(10):1051-1053. 被引量:3
  • 2樊亚文,张志明,岳宏林,艾瑜.右乳腺癌并右下肺癌同期手术一例[J].华北国防医药,2006,18(2):136-136. 被引量:5
  • 3张怡梅,倪海英,朱严冰,孟冀昌,苏同义.重复癌16例临床分析[J].临床误诊误治,2006,19(12):53-55. 被引量:13
  • 4Cuadros M, Cano C, Lopez FJ, et al. HER2 status in breast cancer: experience of a Spanish National Reference Centre [J]. Clin Transl Oncol,2011,13(5) :335 -340.
  • 5Yin W, Jiang Y, Shen Z, et al. Trastuzumab in the adjuvant treatment of HER2-positive early breast cancer patients : a meta-analysis of published randomized controlled trials [ J ]. PLoS One,2011,6 (6) : e21030.
  • 6Scaltriti M, Verma C, Guzman M, et al. Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab- dependent cell cytotoxicity [ J ]. Oncogene, 2009,28 (6) : 803 - 814.
  • 7Sauter G, Lee J, Bartlett JM, et al. Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations [ J ]. J Clin Oncol, 2009,27 (8) :1323 - 1333.
  • 8Cronin M, Pho M, Dutta D, et al. Measurement of gene expression in archival paraffin-embedded tissues : development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay [ J ]. Am J Pathol,2004,164 ( 1 ) :35 - 42.
  • 9Roche PC, Suman VJ, Jenkins RB, et al. Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831[J]. J Natl Cancer Inst, 2002,94( 11 ) :855 - 857.
  • 10Rabiau N, Dechelotte P, Adjakly M, et al. BRCA1, BRCA2,AR and IGF-I expression in prostate cancer: Correlation between RT-qPCR and immunohistochemical detection [ J ]. O ncol Rep ,2011,26 ( 3 ) :695 - 702.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部